Describe the various techniques of phonosurgery in detail for 50 marks with diagram and flow charts from Scott Brown, Cummings, stell and marans, Zakir Hussain, dhingra, hazarika and related articles with recent advances according to rguhs university
phonosurgery techniques vocal fold
RGUHS phonosurgery techniques 50 marks ENT question answer
Scott-Brown's ORL HNS, Ch. 67: "Phonosurgery refers to any surgery designed primarily for the maintenance, restoration or enhancement of the voice."
PHONOSURGERY
|
┌───────────────────┼────────────────────┐
│ │ │
PHONOMICROLARYNGOSCOPY INJECTION LARYNGEAL
(Microlaryngeal Surgery) LARYNGOPLASTY FRAMEWORK
SURGERY
│ │
┌───────┴───────┐ ┌────────┴────────┐
Temporary Permanent Isshiki Types I-IV
Materials Materials + Arytenoid
(Gelfoam, HA) (Silicone, Adduction
Fat) + Cricothyroid
Approximation
PLUS:
└─ RLN REINNERVATION (Selective / Non-selective)
└─ LARYNGEAL PACING
└─ VOCAL FOLD AUGMENTATION (Recent advances)
Cummings, p.1153: Percutaneous medialization by injection should be considered in patients with short life expectancy and aspiration or severe dysphonia.
LAYERS OF VOCAL FOLD (Hirano 1974):
┌─────────────────────────────┐
│ EPITHELIUM (squamous) │ ← Cover
├─────────────────────────────┤
│ SUPERFICIAL LAMINA │ ← Cover (Reinke's space)
│ PROPRIA (SLP) │
├─────────────────────────────┤ ← Transition zone
│ INTERMEDIATE LP │
├─────────────────────────────┤
│ DEEP LP (vocal ligament) │
├─────────────────────────────┤
│ THYROARYTENOID MUSCLE │ ← Body (vocalis)
└─────────────────────────────┘
KEY PRINCIPLE: All surgery must preserve SLP (Reinke's space)
and vocal ligament to prevent scarring and dysphonia
SURGICAL STEPS - Cold Dissection:
Step 1: Suspend laryngoscope - expose both vocal folds
Step 2: Inspect with 70° telescope - confirm bilateral mid-membranous location
Step 3: Grasp centre of nodule with atraumatic forceps
Step 4: Retract medially toward opposite cord
Step 5: Cut mucosa at base with microscissors (cold)
→ Produces straight vibratory edge
→ Prevents secondary notching
Step 6: Repeat contralateral side if needed
(no contraindication to bilateral excision at same sitting)
NOTE: Preserves vocal ligament; avoids Reinke's space entry
SURGICAL STEPS:
Step 1: Suspend + inspect
Step 2: Grasp polyp with atraumatic forceps
Step 3: Apply gentle, steady traction toward opposite cord
Step 4: Section base of polyp (cold instruments or CO2 laser)
Step 5: Check for contact lesion on contralateral fold
(usually should NOT be addressed)
NOTE: Superficial to vocal ligament; wide base = microflap technique
SURGICAL STEPS (Cordotomy technique):
Step 1: Make cordotomy incision on SUPERIOR aspect of VF
(NOT medial edge - preserves vibratory margin)
Step 2: Elevate mucosa carefully with elevator
Step 3: Aspirate or remove myxoedematous/gelatinous contents
Step 4: Replace mucosal flaps
Step 5: Trim excess epithelium
Step 6: Lay flap onto surface; heals by surface tension
IMPORTANT: Only after smoking cessation; bilateral at same setting is safe
MICROFLAP TECHNIQUE (Bouchayer-Cornut):
Step 1: Sickle knife incision along superior surface of VF
(lateral to medial edge)
Step 2: Elevate epithelial-SLP mucosal flap
Step 3: Dissect cyst from surrounding SLP bluntly
Step 4: Remove intact cyst (avoid rupture to prevent recurrence)
Step 5: Replace mucosal flap; no sutures needed
CRITICAL: Preserve vocal ligament; no raw areas on vibratory edge
| Method | Advantage | Disadvantage |
|---|---|---|
| CO2 Laser | Precise, haemostatic | Scarring risk, no histology |
| KTP/PDL Laser (angiolytic) | Targets vasculature, less thermal spread | Office procedure |
| Microdebrider (powered shaver) | Fast, tissue preservation, histology possible | Bleeding |
| Cold steel | No thermal damage | Bleeding |
INJECTABLE MATERIALS FOR LARYNGOPLASTY:
┌──────────────────┬──────────────┬──────────────────────────────┐
│ Material │ Duration │ Notes │
├──────────────────┼──────────────┼──────────────────────────────┤
│ Gelfoam │ 6-8 weeks │ Temporary; reversible │
│ Cymetra (acell. │ 6-12 months │ Micronized AlloDerm; good │
│ dermal matrix) │ │ results; no inflammation │
│ Hyaluronic acid │ 6-12 months │ Favorable viscoelastic props │
│ (Restylane/Juv.) │ │ │
│ Autologous fat │ Long-term │ Slight over-injection needed;│
│ │ │ unpredictable resorption │
│ Collagen │ 3-6 months │ Bovine - inflammatory stiff- │
│ │ │ ness; now largely replaced │
│ Calcium hydroxy- │ Long-term │ Radiesse; granuloma risk; │
│ apatite (CaHA) │ │ caution advised (Cummings) │
│ Silicone │ Permanent │ PTFE/Teflon - DISCOURAGED; │
│ (PTFE/Teflon) │ │ granuloma; airway compromise │
└──────────────────┴──────────────┴──────────────────────────────┘
Note: Calcium hydroxyapatite has REPLACED Teflon as standard (Scott-Brown's)
Scott-Brown's, Key Points: "Materials such as calcium hydroxyapatite have replaced Teflon for vocal fold injection laryngoplasty."
APPROACHES TO VOCAL FOLD INJECTION:
INJECTION LARYNGOPLASTY
│
┌───────────────┼───────────────┐
│ │ │
TRANSORAL PERCUTANEOUS LARYNGOSCOPIC
(Indirect) (Transcutaneous) (Microlaryngoscopy)
│ │ │
Curved laryn- Three routes: Under GA with
geal needle; 1) Lateral suspension; Brunings
topical through syringe; direct
anaesthesia; thyroid ala visualization
patient holds (preferred -
tongue out Cummings)
2) Anterior
via CTM
(subglottic)
3) Transthyrohyoid

ISSHIKI CLASSIFICATION:
TYPE I - MEDIALIZATION THYROPLASTY (Lateral Compression)
├── Goal: Medialize a laterally positioned vocal fold
├── Indications: Unilateral VF paralysis, vocal fold atrophy, sulcus
├── Window dimensions: ~5mm x 13mm, located in inferior half of thyroid ala
├── Implants: Silastic (carved), hydroxyapatite (VoCoM), Gore-Tex
└── Effect: Cord moves medially → improved glottic closure → better voice
TYPE II - LATERALIZATION THYROPLASTY (Expansion)
├── Goal: Open/lateralize the vocal folds (expand glottis)
├── Indication: Bilateral adductor spasmodic dysphonia (adductor SD)
├── A lateral-spreading implant is placed to open the thyroid cartilage
└── Effect: Reduced VF tension and contact → less spasm
TYPE III - RELAXATION THYROPLASTY (Shortening)
├── Goal: Lower pitch by relaxing/shortening the VF
├── Indication: Mutational falsetto (puberphonia), excessively high pitch
├── Technique: Removes small thyroid cartilage section to approximate
│ arytenoids to anterior commissure (shorten VF)
└── Effect: VF shortening → lower fundamental frequency (F0)
TYPE IV - TENSION THYROPLASTY / CRICOTHYROID APPROXIMATION
├── Goal: Raise pitch (increase VF tension)
├── Indication: MTF (Male-to-Female transsexuals), feminization laryngoplasty
│ Unilateral VF paralysis (pitch elevation)
├── Technique: Suture between inferior border of thyroid cartilage and
│ superior border of cricoid cartilage anteriorly
│ (approximates the two cartilages, stretching the VF)
└── Effect: VF elongation → raised F0 → higher (feminine) pitch
THYROPLASTY TYPE I - STEP BY STEP:
Pre-op: Voice assessment, stroboscopy, CT larynx (optional)
Step 1: Patient supine; paramedian horizontal neck incision
(5 cm) over middle of thyroid lamina
Step 2: Subplatysmal flaps; split strap muscles in midline;
retract off ipsilateral thyroid lamina
(preserve outer perichondrium if using Gore-Tex)
Step 3: Define landmarks:
- Thyroid notch (superior)
- Inferior border of thyroid ala
- Midline
Step 4: Window position:
- CRITICAL: Inferior half of thyroid ala
- NOT too superior (displaces false cord - common error)
- Approximate dimensions: 5 mm (height) x 10-13 mm (width)
- Vocal cord lies at midpoint of window
Step 5: Score outer perichondrium with template
Step 6: Create cartilage window (preserve or remove cartilage island)
Preserve inner perichondrium
Step 7: Temporarily displace inner perichondrium medially to assess voice
Step 8: Shape implant (Silastic block or prefabricated system)
VoCoM implants: 3-7 mm displacement variants
Netterville system; Montgomery implants
Step 9: Insert implant while patient phonates (local anaesthesia)
Adjust position until optimal voice achieved
Step 10: Close in layers; drain optional
(NO suturing of implant - remains in window by compression)
Common Error: Window placed TOO HIGH → displaces false cord,
not true cord → poor voice outcome
ARYTENOID ADDUCTION - TECHNIQUE:
Indications: Large posterior glottic gap; paralyzed cord at different
vertical level to normal cord
Access: Extended neck incision; approach posterior thyroid lamina
Step 1: Expose posterior thyroid ala
Step 2: Identify and dissect muscular process of arytenoid
Step 3: Divide attached muscles (posterior cricoarytenoid, interarytenoid)
Step 4: Place suture through muscular process
Step 5: Rotate arytenoid to adducted position by pulling suture anteriorly
(simulates adductor muscle pull)
Step 6: Fix suture to inferior horn of thyroid cartilage
Step 7: Combine with Type I thyroplasty for optimal results
Result: Closes posterior glottic gap; corrects vertical height discrepancy
CTA - TECHNIQUE:
Step 1: Horizontal incision at level of CTM
Step 2: Expose cricoid and inferior thyroid borders anteriorly
Step 3: Place 2-3 permanent sutures between thyroid inferior border
and cricoid superior border
Step 4: Tie under phonation until desired pitch achieved
(local anaesthesia - patient phonates "ee")
Step 5: Final F0 increase: typically 50-100 Hz above baseline
Alternative: Glottoplasty (Wendler); Laser vocal fold shortening (recent)
REINNERVATION FLOWCHART:
VF PARALYSIS
│
├── UNILATERAL
│ │
│ ├── Short-term/uncertain recovery
│ │ └── INJECTION LARYNGOPLASTY (temporary)
│ │
│ └── Permanent/12 months wait
│ ├── TYPE I THYROPLASTY ± Arytenoid adduction
│ └── ANSA-RLN REINNERVATION (± thyroplasty)
│
└── BILATERAL
│
├── Airway compromise → TRACHEOSTOMY (acute)
│
└── Long-term management:
├── Laser posterior cordotomy / arytenoidectomy
└── SELECTIVE REINNERVATION (PCA)
LASER OPTIONS:
┌──────────────────┬────────────┬────────────────────────────────┐
│ Laser Type │ Wavelength │ Application │
├──────────────────┼────────────┼────────────────────────────────┤
│ CO2 │ 10,600 nm │ Standard; precise ablation; │
│ (gold standard) │ │ vaporizes tissue; no histology │
│ KTP (532 nm) │ 532 nm │ Angiolytic; vasc. lesions; │
│ │ │ RRP; hemorrhagic polyps; │
│ │ │ office-based procedure │
│ Pulsed dye laser │ 585 nm │ Angiolytic; RRP; papillomatosis│
│ (PDL) │ │ │
│ Nd:YAG │ 1064 nm │ Deeper penetration; hemangioma │
│ Diode │ 810/980 nm │ Contact cutting; hemostasis │
└──────────────────┴────────────┴────────────────────────────────┘
CO2 Laser Parameters (Scott-Brown):
- Spot size: 0.5-1.0 mm (microspot = 0.2-0.3 mm)
- Power: 2-5 W for VF surgery
- Mode: Pulsed/SuperPulse preferred (less thermal spread)
- Tissue effect: Vaporization > coagulation
HAZARDS: Endotracheal tube fire; eye protection; smoke plume
| Advance | Details |
|---|---|
| Stem cell therapy | Mesenchymal stem cells + hyaluronic acid scaffolds for VF scar repair (experimental) |
| Platelet-rich plasma (PRP) | Autologous PRP injection for VF scar and sulcus; promotes lamina propria regeneration |
| Biomaterial scaffolds | HA-based hydrogels with viscoelastic properties matching native SLP (e.g., Prolaryn, Juvederm Vocal) |
| Robotic phonosurgery | Transoral robotic surgery (TORS) extending to microsurgery; increased precision |
| Laser refinements | Thulium laser (2013 nm); 532 nm KTP/PDL for office RRP with reduced scarring vs CO2 |
| Glottoplasty modifications | Wendler's laser glottoplasty and anterior glottal web creation for pitch elevation in MTF |
| Nerve transfer innovations | Hypoglossal-RLN anastomosis; combined reinnervation + thyroplasty approaches |
| 3D-printed implants | Patient-specific thyroplasty implants using 3D printing for optimal medialization |
| Bevacizumab (Avastin) | Anti-VEGF intralesional injection for recurrent RRP (PMID 37433709) |
| HPV vaccination | Gardasil 9 reduces RRP recurrence rates; prophylactic for juvenile-onset RRP |
Recent systematic review (Maniaci et al., Am J Otolaryngol 2024, PMID 38071789): Surgical techniques for sulcus vocalis show variable outcomes; no single technique definitively superior; combination of mucosal techniques with augmentation shows best perceptual and acoustic results.
COMPLICATIONS:
PHONOMICROSURGERY:
├── Immediate: Dental trauma, laryngospasm, subglottic edema
├── Early: Hematoma, infection, granuloma at contact areas
└── Late: VF scar (most dreaded), synechiae (anterior commissure
web), incomplete excision → recurrence
INJECTION LARYNGOPLASTY:
├── Over-injection → airway compromise, stiff voice
├── Under-injection → persistent dysphonia
├── Misplaced injection into Reinke's space → stiffness
├── Teflon/PTFE granuloma (historical)
├── CaHA granuloma (rare, reported in literature - Cummings)
└── Infection, haematoma
FRAMEWORK SURGERY:
├── Implant extrusion (Gore-Tex reported - Cummings)
├── Implant malposition (too superior = most common error)
├── Airway compromise (over-medialization)
├── Infection of implant
└── Granulomatous reaction (foreign body)
PATIENT WITH DYSPHONIA
│
▼
FULL ASSESSMENT
(History, stroboscopy, acoustic analysis, VHI)
│
▼
DIAGNOSIS
┌──────────────────────────────────────────────┐
│ │
BENIGN LESIONS VOCAL FOLD PARALYSIS
(Nodule, Polyp, ┌──────────┴──────────┐
Cyst, Reinke's) UNILATERAL BILATERAL
│ │ │
▼ │ Airway threatened?
VOICE THERAPY (SLT) │ YES → Tracheostomy
│ ▼ NO → Laser arytenoidectomy
▼ <12 months? / Selective reinnervation
FAILS or Injection
RECURS? laryngoplasty
│ (temporary)
▼ │
PHONOSURGERY >12 months
• Microflap (permanent)
• Cold dissection │
• Laser ▼
• Cordotomy TYPE I THYROPLASTY
(Reinke's) ± Arytenoid adduction
± Reinnervation
| Type | Name | Goal | Indication | Effect on Pitch |
|---|---|---|---|---|
| I | Medialization thyroplasty | Medialize VF | Unilateral VF paralysis, atrophy | Mild rise (closures better) |
| II | Lateralization thyroplasty | Open glottis | Adductor spasmodic dysphonia | Lower |
| III | Relaxation thyroplasty | Shorten VF | Puberphonia, mutational falsetto | Lower F0 |
| IV | Cricothyroid approximation | Tighten/lengthen VF | MTF transsexual; VF paralysis (pitch) | Raise F0 |